Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase‐4 Inhibitor: A Randomized, Double‐Blinded, Placebo‐Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.895 ◽

2021 ◽

Author(s):

Min Wu ◽

Qian‐Qian Li ◽

Hong Zhang ◽

Xiao‐Xue Zhu ◽

Xiao‐Jiao Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Daily Administration ◽

Pharmacokinetics And Pharmacodynamics ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Double Blinded

Download Full-text

First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Clinical Drug Investigation ◽

10.1007/s40261-021-01088-5 ◽

2021 ◽

Author(s):

Lu Wang ◽

Jinmiao Lu ◽

Sufeng Zhou ◽

Yuqing Zhao ◽

Lijun Xie ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Food Effect ◽

Dipeptidyl Peptidase ◽

Pharmacokinetics And Pharmacodynamics ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

The dipeptidyl peptidase-4 inhibitor vildagliptin does not affect ex vivo cytokine response and lymphocyte function in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2013.12.039 ◽

2014 ◽

Vol 103 (3) ◽

pp. 395-401 ◽

Cited By ~ 12

Author(s):

P.C.M. van Poppel ◽

M.S. Gresnigt ◽

P. Smits ◽

M.G. Netea ◽

C.J. Tack

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Ex Vivo ◽

Dipeptidyl Peptidase ◽

Cytokine Response ◽

Lymphocyte Function ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Effects of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin on Blood Pressure in Hypertensive Patients with Type 2 Diabetes Mellitus

American Journal of Hypertension ◽

10.1093/ajh/hpz065 ◽

2019 ◽

Vol 32 (7) ◽

pp. 695-702 ◽

Cited By ~ 9

Author(s):

Shinji Kishimoto ◽

Yoshihiko Kinoshita ◽

Takeshi Matsumoto ◽

Tatsuya Maruhashi ◽

Masato Kajikawa ◽

...

Keyword(s):

Diabetes Mellitus ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Hypertensive Patients ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus

Cancer Management and Research ◽

10.2147/cmar.s215107 ◽

2019 ◽

Vol Volume 11 ◽

pp. 7427-7438 ◽

Cited By ~ 2

Author(s):

Yeo Jin Choi ◽

Dae Jung Kim ◽

Sooyoung Shin

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cancer Risk ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Incident Cancer

Download Full-text

Risk of Diabetic Retinopathy associated with Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Metformin in Type 2 Diabetes Mellitus

Yakhak Hoeji ◽

10.17480/psk.2020.64.5.402 ◽

2020 ◽

Vol 64 (5) ◽

pp. 402-408

Author(s):

Eunmi Choi ◽

Soo Youn Chung ◽

Bonggi Kim ◽

Jeonghoon Ahn ◽

Soon Young Han

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Diabetic Retinopathy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus

Expert Review of Endocrinology & Metabolism ◽

10.1586/eem.12.69 ◽

2013 ◽

Vol 8 (1) ◽

pp. 21-35 ◽

Cited By ~ 1

Author(s):

Thomas Forst ◽

Andreas Pfützner

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Clinical Overview

Download Full-text

Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

Journal of Pharmacology and Pharmacotherapeutics ◽

10.4103/0976-500x.85934 ◽

2011 ◽

Vol 2 (4) ◽

pp. 230 ◽

Cited By ~ 14

Author(s):

DarshanJ Dave

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Laparoscopic Sleeve Gastrectomy and Dipeptidyl Peptidase-4 Inhibitor which Led to the Improvement of Long-Term Continued Type 2 Diabetes Mellitus

The Japanese Journal of Gastroenterological Surgery ◽

10.5833/jjgs.2012.0191 ◽

2013 ◽

Vol 46 (5) ◽

pp. 334-341

Author(s):

Masatsugu Kojima ◽

Hiroshi Yamamoto ◽

Satoshi Ugi ◽

Satoshi Murata ◽

Tsuyoshi Yamaguchi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice

Drug Discoveries & Therapeutics ◽

10.5582/ddt.2020.03073 ◽

2020 ◽

Vol 14 (5) ◽

pp. 218-225

Author(s):

Junkichi Kanda ◽

Megumi Furukawa ◽

Nobuo Izumo ◽

Taketoshi Shimakura ◽

Noriaki Yamamoto ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Bone Fragility ◽

Obese Mice ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus

American Journal of Health-System Pharmacy ◽

10.2146/ajhp090555 ◽

2010 ◽

Vol 67 (18) ◽

pp. 1515-1525 ◽

Cited By ~ 21

Author(s):

Joshua J. Neumiller ◽

R. Keith Campbell

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text